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Abstract
Background
The increased use of medical therapies has led to increased medical costs. To pro-
vide insight into the value of this increased spending, we compared gains in life ex-
pectancy with the increased costs of care from 1960 through 2000.
Methods
We estimated life expectancy in 1960, 1970, 1980, 1990, and 2000 for four age groups. 
To control for the influence of nonmedical factors on survival, we assumed in our base-
case analysis that 50 percent of the gains were due to medical care. We compared the 
adjusted increases in life expectancy with the lifetime cost of medical care in the 
same years.
Results
From 1960 through 2000, the life expectancy for newborns increased by 6.97 years, 
lifetime medical spending adjusted for inflation increased by approximately $69,000, 
and the cost per year of life gained was $19,900. The cost increased from $7,400 per 
year of life gained in the 1970s to $36,300 in the 1990s. The average cost per year 
of life gained in 1960–2000 was approximately $31,600 at 15 years of age, $53,700 at 
45 years of age, and $84,700 at 65 years of age. At 65 years of age, costs rose more rap-
idly than did life expectancy: the cost per year of life gained was $121,000 between 
1980 and 1990 and $145,000 between 1990 and 2000.
Conclusions
On average, the increases in medical spending since 1960 have provided reasonable 
value. However, the spending increases in medical care for the elderly since 1980 are 
associated with a high cost per year of life gained. The national focus on the rise in 
medical spending should be balanced by attention to the health benefits of this in-
creased spending.
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A 
dvances in medical care have led 
to sustained increases in medical spending 
over time. Adjusted for inflation, annual 
medical spending per person has increased from 
approximately $700 in 1960 to more than $6,000 
today, tripling as a share of the gross domestic 
product (GDP).1 At least half this increase is a 
result of more care, not higher prices for exist-
ing care.2
An evaluation of whether increased medical 
spending is useful requires the valuation of the 
increase in care. The enormous growth in spend-
ing has led many to argue that the increasing 
costs are excessive.3 Others, however, suggest that 
spending more may provide good value, whether 
measured in costs per year of life gained or in 
overall measures of economic benefit.4-7 The vast 
literature on the cost-effectiveness of specific 
medical treatments and other interventions sug-
gests that many (though certainly not all) medi-
cal treatments provide reasonable value.8 How-
ever, there has been comparatively little effort to 
understand the value of the medical system as a 
whole: Is the increase in spending by more than 
a factor of eight worth it?
We addressed this question by examining how 
medical spending has translated into gains in sur-
vival. We measured the increase in medical spend-
ing from 1960 through 2000 and compared it with 
the number of additional years of life lived, fo-
cusing on the gains in life expectancy that were 
likely to be due to medical care. We assumed in 
our base case that 50 percent of improvements 
in longevity resulted from medical care. We also 
conducted sensitivity analyses using various as-
sumptions about the proportion of life-expectancy 
gains that was attributable to health care.
Methods
We estimated life expectancies and the projected 
medical spending for four age groups in 1960, 
1970, 1980, 1990, and 2000, according to the mor-
tality rates and costs that prevailed in each year. 
For example, when calculating the lifetime costs 
(i.e., costs from birth) of health care for a newborn 
in 1960, we used the 1960 values for spending in 
all ages. In this way, we obtained an accurate pic-
ture of the medical system as it existed at each time, 
and we were able to explore how that picture 
changed over time.
Life Expectancy
Our data on life expectancy were based on U.S. 
life tables for 1959–1961, 1969–1971, 1979–1981, 
1989–1991, and 2000.9 For simplicity, we refer to 
the three-year periods by the middle year (1960, 
1970, 1980, 1990). To estimate changes in life ex-
pectancy according to cause, we used cause-dele-
tion methods.10 Specifically, we obtained the rates 
of death from each cause in 1960 according to age. 
We then added the age-specific change in the mor-
tality rate between 1960 and 2000 for a particu-
lar cause to the age-specific overall mortality rate 
in 1960 and calculated the life expectancy accord-
ing to the new mortality rate. The difference be-
tween the life expectancy calculated with the new 
mortality rate and the life expectancy in 1960 was 
considered to reflect the effect of that cause on 
life expectancy.
We assumed that a portion of the gains in life 
expectancy were related to medical care. Analyses 
aggregated from treatments clearly shown to be 
medically effective suggest that at least half the 
life-expectancy gains since 1950 are due to medi-
cal advances.11-13 About 90 percent of the gains in 
life expectancy are attributable to improvements 
in the rates of death in infancy and the rates of 
death from cardiovascular disease. Prevailing esti-
mates suggest that at least half the reduction in 
these rates are due to medical care.4,14-23 We there-
fore assumed in our base case that 50 percent of 
the total gains in life expectancy were due to 
medical care.
We examined this assumption by considering 
the importance of two causes of death that are 
unlikely to be due to changing medical treatment. 
The first was death attributable to smoking. Rates 
of smoking among adults fell from 42 percent in 
1960 to 22 percent in 2000. To estimate the chang-
es in life expectancy that were attributable to re-
duced rates of smoking, we constructed an alter-
native time series for mortality in 1970, 1980, 
1990, and 2000, assuming that smoking rates 
were fixed at 1960 levels — in essence, assuming 
that none of the decline in the rate of smoking 
was due to medical treatment. Data on the preva-
lence of smoking were from the National Health 
Interview surveys for 1965–200024 and from a sur-
vey of adolescents in California.25 Because the 
surveys did not collect information on smoking 
until 1965, the ratio of per capita cigarette use in 
1960 was compared with that for 1965 to extrapo-
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late the prevalence data before 1965.26 By combin-
ing the prevalence of smoking with the relative 
risk of death for smokers,27 we could estimate the 
contribution of reduced rates of smoking to in-
creased longevity.
The second cause we investigated was the rate 
of death from external factors: accidents (most 
commonly involving motor vehicles), suicide, and 
homicide. The rates of death from external causes 
have declined by 44 percent since 1960. Although 
this decline is partly related to medical care (bet-
ter emergency room care, for example), trends in 
survival are likely to reflect other factors to a far 
larger degree.20 To estimate the effect of chang-
es in the rate of death from external causes, we 
assumed that the rate was the same in 1970, 1980, 
1990, and 2000 as it was in 1960.
The effect of medical care on improvements in 
health is uncertain. We therefore performed sen-
sitivity analyses on the percentage of gains in life 
expectancy that was assumed to be due to medi-
cal care.
Medical Spending
We obtained data on medical spending according 
to age from Meara et al.28 These researchers esti-
mated spending for five years for which health-
expenditure surveys were available: 1963, 1970, 
1977, 1987, and 2000. Spending was defined as 
total medical costs; we did not consider the indi-
rect costs of medicine, such as improvements in 
productivity. We interpolated and extrapolated the 
data by using national spending trends to estimate 
age-specific spending in 1960, 1970, 1980, 1990, 
and 2000. Lifetime costs were calculated with the 
use of the probability of survival to each age. All 
spending was adjusted to 2002 dollars with the use 
of the GDP deflator and was discounted at a rate 
of 3 percent. The discounting, combined with the 
fact that not all people live to an advanced age, 
meant that the current value of lifetime spending 
at a younger age need not have exceeded the cur-
rent value of spending at an older age.
Value of Medical Care
To measure the value of care, we divided the change 
in spending from one decade to the next (incre-
mental costs) by the change in life expectancy 
from one decade to the next (incremental health 
benefits). We calculated the number of dollars 
spent per year of life gained during the entire life 
span (i.e., from birth to death) for 1960, 1970, 
1980, 1990, and 2000 individually and for the four-
decade period as a whole. We also estimated the 
costs per year of life gained between 15 years of 
age and death, 45 years of age and death, and 65 
years of age and death by including the medical 
costs incurred and the increase in life expectancy 
after each age. A lower ratio of dollars spent to 
years of life gained indicated a better value (i.e., 
less money paid for each one-year increase in life 
expectancy).
Results
The remaining life expectancy for four age groups 
(newborn and 15, 45, and 65 years of age) is listed 
in Table 1. The life expectancy for newborns in-
creased by 6.97 years between 1960 and 2000. At 
3.12 years, the increase in life expectancy between 
1970 and 1980 was the largest increase during 
any decade. The increase was 0.86 year between 
1960 and 1970, 1.5 years between 1980 and 1990, 
and 1.49 years between 1990 and 2000. The mor-
tality rate fell between 1960 and 2000 for each age 
group. 
The causes of the increases in life expectancy 
for newborns between 1960 and 2000 are shown 
in Table 2. Of the 6.97-year increase in life expec-
tancy, 4.88 years (70 percent) resulted from a re-
Table 1. Life Expectancy According to Age Group and Year, 1960–2000.
Age Life Expectancy
Cumulative Change
(1960–2000)
1960 1970 1980 1990 2000
years
Newborn 69.90 70.76 73.88 75.37 76.87 6.97
15 Yr 57.33 57.69 60.19 61.38 62.62 5.29
45 Yr 29.50 30.12 32.27 33.44 34.38 4.88
65 Yr 14.39 15.00 16.51 17.28 17.86 3.47
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duced rate of death from cardiovascular disease. 
An additional 1.35 years (19 percent) resulted from 
a reduced rate of death in infancy. A reduced rate 
of death from external causes led to an additional 
increase of 0.36 year (5 percent). The reduction 
in the rate of death from smoking (included in 
the rate of death from cardiovascular disease and 
other causes) led to an increase in life expectancy 
of 1.1 years (16 percent) (data not shown). The 
combined effect of reduced rates of death from 
external causes and smoking, 21 percent, is less 
than the increase in longevity of 50 percent that 
we attributed to nonmedical factors.
Estimates of the present value of medical spend-
ing for each of the four age groups, calculated with 
the use of age-specific spending rates that pre-
vailed in each year, are listed in Table 3. In 1960, 
lifetime spending from birth was about $14,000 
per person. That amount had increased to more 
than $83,000 by 2000, an increase by a factor of 
nearly six. At older ages, medical spending in-
creased even more between 1960 and 2000 — by 
a factor of more than 13 for people 65 years of age 
or older, for example.
The lifetime incremental costs per year of life 
gained, based on the assumption that 50 percent 
of such increases were due to medical care, are 
shown in Figure 1. From birth, during the entire 
period from 1960 through 2000, an average of 
$19,900 was spent per year of life gained. Costs 
per year of life gained were lower in the first two 
decades than in the third and fourth decades but 
costs per year of life for newborns never exceeded 
$40,000 per year. At older ages, there were sub-
stantial increases in the cost of each additional 
year of life gained. For example, the average cost 
per year of life gained at 65 years of age was about 
$84,700 during the entire 1960–2000 period but 
rose from $75,100 between 1960 and 1970 to 
$145,000 between 1990 and 2000.
We used sensitivity analyses to examine how 
varying the proportion of increases in life expec-
tancy gains assumed to be due to medical care 
would affect the estimates of cost-effectiveness 
(Fig. 2). If 25 percent of the gains in life expec-
tancy were due to health care, then the average 
cost per year of life gained between 1960 and 
2000 would have ranged from $39,800 at birth 
to $169,400 at 65 years of age. According to this 
scenario, each one-year increase in life expectancy 
cost more than $70,000 between 1990 and 2000 
for each age group. Conversely, if 75 percent of the 
increase in life expectancy were due to health care, 
then the average cost per year of life gained be-
tween 1960 and 2000 would have ranged from 
$13,300 for newborns to $56,500 for people 65 
years of age or older.
Discussion
Medical spending has increased at more than 10 
percent per year for most of the past four decades, 
largely as a result of the development and wide-
spread use of new medical techniques.2 This dra-
matic increase in spending has contributed to 
political pressure to restrain costs.3 Yet one of the 
most important questions remains unanswered: 
What is the value of this medical spending? We 
attempted to answer that question by comparing 
the trends in spending with the trends in life ex-
pectancy. During the period from 1960 through 
2000, we estimated that increased spending on 
health care at birth resulted in an average cost of 
$19,900 per year of life gained. In analyses includ-
ing spending and the increase in life expectancy for 
people 65 years of age, the average cost per addi-
tional year of life was about $84,700.
The value of a year of life as used in medical 
decision-making (known as the value of a statis-
tical life) is the subject of some debate. Viscusi and 
Aldy29 estimated the value of a statistical life for 
people of working age at approximately $7 million. 
For a person who is roughly 45 years old and thus 
has a remaining life expectancy of 30 years, the 
value is more than $200,000 per year of life re-
Table 2. Causes of Increases in Life Expectancy among Newborns, 
1960–2000.*
Cause
Increase in Life 
Expectancy
Relative 
Contribution
yr %
Reduction in rate of death from cardio-
vascular disease
4.88 70
Reduction in rate of death in infancy 1.35 19
Reduction in rate of death from external 
causes
0.36 5
Reduction in rate of death from pneumo-
nia or influenza
0.28 4
Reduction in rate of death from cancer 0.19 3
Total 6.97 100
* The data do not sum to the total because of slight increases in the rates 
of death from other causes (not listed) and because of rounding. 
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maining.7 Some studies recommend a value of 
$100,000 per year of life,4,30 whereas the National 
Institute for Health and Clinical Excellence, whose 
analysis is used to inform decisions about health 
coverage by the British National Health Service, 
seems to use a value of £25,000 to £35,000 per year 
of life (roughly $50,000) as a general upper limit, 
though this is not specifically stated as policy.31
According to virtually any commonly cited value 
of a year of life, we found that if medical care 
accounts for about half the gains in life expec-
tancy, then the increased spending has, on aver-
age, been worth it. However, the current trends 
are a cause for concern. There has been a sharp 
increase in the cost per additional year of life 
gained during the past two decades, primarily 
among the elderly. Analyses focused on spending 
and on the increase in life expectancy beginning 
at 65 years of age showed that the incremental 
cost of an additional year of life rose from $46,800 
in the 1970s to $145,000 in the 1990s. The former 
amount certainly reflects a good value, but the lat-
ter fails to meet many cost–benefit criteria. Fur-
thermore, it appears that although the rate of in-
crease in spending had stabilized, if not declined, 
by 2000 for the newborn and 15-year-old groups, 
this  rate  is  substantially  outpacing  the  rate  of 
increase in life expectancy in older age groups. 
If this trend continues in the elderly, the cost-
effectiveness of medical care will continue to de-
crease at older ages.
The reasons for the substantially increased cost 
per year of life gained in older age groups cannot 
be ascertained from our analyses, although other 
investigators have examined possible reasons.3 
One is that the “low-hanging fruit” (less expensive 
therapies such as antihypertensive medications) 
were picked first, and incremental advances there-
after have necessarily been more costly. Another 
is that relatively more care for elderly patients 
than for younger patients is palliative or residen-
tial, which results in increased spending for the 
elderly and does improve quality of life but may 
not improve longevity.
Clearly, not all improvements in the mortality 
rate resulted from medical spending, but we used 
a conservative method to estimate the percentage 
that did. Consistently with past analyses,11-13 we 
assumed that only 50 percent of the reduction in 
the mortality rate was due to medical care. This 
assumption is likely to be reasonable, given our 
Table 3. Present Value of Average Medical Spending per Person According to Age Group and Year.*
Age Average per Capita Spending
Cumulative Change
(1960–2000)
1960 1970 1980 1990 2000
$
Newborn 13,943 25,528 37,085 56,120 83,307 69,364
15 Yr 18,700 32,704 47,155 69,457 102,490 83,790
45 Yr 17,141 35,266 63,275 100,983 148,014 130,873
65 Yr 11,495 34,526 69,819 116,097 158,549 147,054
* Values are expressed in 2002 U.S. dollars. Costs were discounted with the use of an interest rate of 3 percent. Because 
of this discounting and the fact that not everyone lives to an advanced age, the present value of lifetime spending at 
younger ages need not exceed the present value of spending at older ages.
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Figure 1. Longitudinal Trends in the Costs per Year of Life Gained in Four 
Age Groups.
Spending per year of life gained was defined by the change in spending 
over the decade divided by the change in expected years of life over the 
decade.
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finding that 90 percent of the increases in life ex-
pectancy during the past four decades have re-
sulted from reductions in the rate of death from 
cardiovascular disease and death in infancy. Al-
though reductions in the rate of death from cardio-
vascular causes are multifactorial, prior research 
has suggested that at least half the reductions in 
the rate have resulted from medical advances.14-17 
Among infants, more than half the reduction in 
the mortality rate between 1960 and 2000 resulted 
from a reduced rate of neonatal death among low-
birth-weight infants (weighing <2500 g), which is 
due almost entirely to medical advances.18,19,21-23
To validate our assumption, we considered 
other factors that were unlikely to be the result of 
medical care. Reduced rates of death from exter-
nal causes and death related to smoking together 
accounted for 21 percent of the increase in lon-
gevity, well below the 50 percent that we attrib-
uted to nonmedical factors. Even if only 25 per-
cent of the gains in longevity were due to medical 
care, the value of medical care is reasonable, on 
average.
Our primary conclusion is that although med-
ical spending has increased over time, the return 
on spending has been high. In considering health 
policy, the concern about high medical costs needs 
to be balanced by the benefits of the care re-
ceived.
Our results contrast with the conclusions that 
are often drawn from international data. The 
United States spends more on health care than 
other countries do, with similar or poorer overall 
outcomes. Of course, differences in culture, life-
style, and social systems may confound these in-
ternational comparisons. Still, it is clear that the 
U.S. health care system is not as efficient as it 
could be,32 and improving its efficiency is an im-
portant goal. However, our results suggest that the 
increase in spending is not solely attributable to 
an increase in inefficiency. Indeed, medical spend-
ing has increased at roughly the same rate in all 
countries.2,33 Taken as a whole, the average return 
on the increased spending has been high.
One possible scenario for the future of health 
care is that the costs per year of life gained will 
continually increase, resulting in wasted resourc-
es. However, extrapolation of any kind is inher-
ently uncertain, and particularly so for medical 
advances. The genetic revolution is opening new 
avenues for medical inquiry, and some very cost-
effective therapies could emerge. In addition, 
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Figure 2. Results of Sensitivity Analyses of the Percentage of the Increase in Life Expectancy Assumed to Be Due to Medical Care 
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quality-improvement initiatives could increase the 
value of every dollar spent.
A number of limitations of our study should 
be mentioned. First, our estimate that 50 percent 
of the increase in longevity results from medical 
care is uncertain. Although reduced rates of death 
from tobacco use and from external causes ac-
counted for only 21 percent of the increase in life 
expectancy, we did not consider all causes of 
changes in life expectancy that were due to non-
medical interventions. The most obvious omis-
sions were the increased rate of obesity and the 
spread of acquired immunodeficiency syndrome, 
each of which results in worsened health. Second, 
our analysis was based on mortality alone, not on 
changes in the quality of life. Consistent data on 
the quality of life were not available for the pe-
riod from 1960 through 2000. However, studies 
suggest that there were substantial improvements 
in the quality of life during this period, especially 
among the elderly.13,34 Thus, our estimates are 
likely to have understated the value of medical 
spending. Finally, although we excluded gains in 
life expectancy that were due to nonmedical inter-
ventions, we did not exclude their associated costs, 
owing to the difficulty of disaggregating them 
from the overall costs of health care. This resulted 
in the overstatement of cost increases and thus the 
understatement of the value of medical advances.
In conclusion, although medical spending has 
increased substantially during the past 40 years, 
the money spent has provided good value. How-
ever, temporal trends suggest that the value of 
health care spending is decreasing over time, par-
ticularly for older age groups. We need to continue 
tracking trends in health care spending and its 
benefits to ensure that resources are allocated 
wisely. Such efforts should focus on specific dis-
eases in order to provide a more detailed picture 
of the value of health care both within disease 
categories and across a spectrum of common dis-
eases over time. Also, the United States should 
modify its system of tracking the health sector 
to include a measure of population health in ad-
dition to spending, so that policymakers and the 
public have an informed picture of the benefits 
obtained for the money spent.
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